WO2012129957A1 - Différentes formulations pharmaceutiques - Google Patents
Différentes formulations pharmaceutiques Download PDFInfo
- Publication number
- WO2012129957A1 WO2012129957A1 PCT/CN2012/000061 CN2012000061W WO2012129957A1 WO 2012129957 A1 WO2012129957 A1 WO 2012129957A1 CN 2012000061 W CN2012000061 W CN 2012000061W WO 2012129957 A1 WO2012129957 A1 WO 2012129957A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treating
- formula
- pharmaceutical formulation
- vitamin
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Definitions
- the invention relates to the treatment of rough skin, aging, plaque, subcutaneous pigmentation, and can be used as a cosmetic and skin care product; an improved preparation of berberine supernatant for treating cancer, cerebral hemiplegia, psychosis, and acne; relating to treating athlete's foot
- the pharmaceutical preparation can be made into a powder or a solution; and relates to a pharmaceutical preparation for treating a cold, which is a traditional Chinese medicine preparation using Chinese herbal medicine as a raw material. Background technique
- the skin care products market is dazzling, numerous, and the effects are very general; cancer, cerebral hemorrhage, hemiplegia, mental illness is almost incurable, the number of patients is more than several billion, the use of surgery for cancer, radiotherapy and chemotherapy, the effect is very small, only Temporarily maintain life, and cerebral hemorrhage is almost incurable.
- Psychosis is mainly based on taking a rest and rest in western medicine. The curative effect is general and it will often recur.
- the hemorrhoids are more than ten people, the disease is more extensive, the western medicine cures for a long period of time, and the surgery is severely treated.
- the object of the present invention is to provide several pharmaceutical formulations, including drugs for treating rough skin, treating cancer, etc., treating athlete's foot and the like; and treating colds and the like.
- the medicine for treating rough skin and the like is a characteristic against the skin, utilizing the effect of estrogen and the bactericidal and anti-scurvy effect of vitamin C, plus edible alkali or medical alkali, preferably baking soda, adjusting the skin Alkaline state.
- Estrogen, vitamins, and baking soda are added to ordinary cosmetics in a certain proportion.
- the invention adopts estrogen as the main material, plus vitamins and edible or medical alkali, has good cosmetic effect, low cost, quick effect and great promotion value.
- the medicine for treating cancer and the like is directed to the pathological characteristics of hemiplegia, psychosis and hemorrhoids of cerebral hemorrhage.
- the cancer is local tissue qi stagnation and blood stasis, toxin deposition, and the tissue cells and toxins of the affected part are counterbalanced or protectively abnormally split.
- Tumor like the automatic healing of wounds, is a self-protection gene in human cells, that is, self-protection and self-protection functions of human cells and oysters.
- the cells of qi stagnation and blood stasis are damaged by toxins, which will protect against rapid abnormalities.
- Psychosis is a long-term depression, depression or anger.
- the brain's nervous system secretes a toxin that injures the nervous system and causes schizophrenia, commonly known as short-circuit.
- Hemorrhoids are caused by constipation.
- the rectum in the rectum is dry, absorbs the moisture in the blood in the blood vessels of the rectum, causing the blood to become sticky and stagnant, blocking the swelling of the blood vessels and forming hemorrhoids.
- toxins in traditional Chinese medicine refer to virtual fire and qi stagnation and blood stasis caused by several kinds, while in traditional Chinese medicine
- the Chinese patent medicine Huanglian Shangqing tablets can treat several diseases mentioned above.
- the peppermint in the scutellaria chinensis tablets can dissipate qi stagnation and blood stasis, and other pharmaceutical ingredients can eliminate the virtual fire, that is, toxins, if supplemented with ginseng honey and other qi
- the drug* can play a role in strengthening the body and eliminating evil spirits, so that the body is in a healthy state with strong blood and blood, and can better cure several diseases.
- Most of the above treatments are hands-on experience and the results are very good.
- the treatment of several diseases only needs to adjust the formula of Huanglian Shangqing Tablets to achieve the purpose of removing medicines.
- the patients with several diseases are mostly acidic, and the formula is slightly alkaline and resistant. Blood vitamin C.
- the medicine for treating athlete's foot is characterized in that it is generally acidic for athlete's foot fungal infection, and the killing effect of vitamin c on athlete's foot fungus, and a combination of medical soda or sodium bicarbonate or sodium carbonate is used to prepare a powder or a solution.
- the object of the present invention is to provide a pharmaceutical preparation for treating athlete's foot, which can achieve low cost and quick curative effect by using a combination of several formulas and medicines, and is generally cured by two or three times; in addition, the present invention is suitable for various fungal infections. Ulcerative skin disease.
- the traditional Chinese medicine preparation for treating colds can achieve low cost by utilizing the combined effects of various flavors of Chinese herbal medicines, and the effect is quick, and the treatment can be generally performed in about three days.
- the invention is suitable for the development of a cold virus under acidic conditions, or the infected part is acidic, and the medical soda is sodium bicarbonate or sodium carbonate, and the sodium benzoate is used in the present; secondly, the symptom selection for nasal congestion is improved.
- the amount of mint used is functional; the vitamin C having anti-cold function is further increased, and other pharmaceutical ingredients.
- the present invention is exemplified by the compound flu.
- the main components of Compound Ganmao Ling tablets include: honeysuckle. Wuzhigan. Wild chrysanthemum. Trigeminal. South Ban GmbH. Gangmei. Acetaminophen. Chlorpheniramine maleate. Caffeine.
- the experience of the party is very effective, and it is supplemented with vinegar fumigation. It can cure the cold in two or three days.
- the invention can also be used for treating atypical pneumonia. '
- lung diseases such as colds, tuberculosis, SARS, bronchitis and other respiratory diseases
- Treatment of lung diseases can be treated in the form of a mask or a gas mask. Direct attack on the lesion, just place the appropriate medication on the mask.
- the invention is a pharmaceutical formulation.
- the medicine for treating rough skin and the like is taken as a case of Meijiajing Dabao, and the specific formula is as follows - about 5% of estrogen, about 10% of vitamin C, and about 5% of baking soda are added to Meijiajing or Dabao, male: The use of cosmetics to reduce estrogen to about 3%, other formula materials are diminishing, the manufacturing process is the same as the United States and Canada and Dabao.
- the invention adopts estrogen as the main material, plus vitamins and edible or medical alkali, has good cosmetic effect, low cost, quick effect and great promotion value.
- the medicine for treating cancer and the like is formulated as follows:
- Hemorrhoids Increase the mint in the formula of Huanglian Shangqing to about 20%, and then add about 10% of honey.
- the other drugs in the formulation of Huanglian Shangqing tablets are reduced.
- the practice is the same as that of Huanglian Shangqing tablets.
- the mixture of peppermint juice and paraffin wax is used as a topical drug in the form of Kaisailu.
- the above-mentioned drug formula is mainly based on qi and qi and detoxification. It mainly utilizes the function of tonifying blood circulation and removing blood stasis and refreshing other drugs in the formula.
- the medicine for treating athlete's foot and the like is made of the following components:
- the medicine for treating athlete's foot is applied to the affected part, and is usually cured two or three times.
- the preparation is also suitable for ulcerative skin diseases of other fungal infections, and has low cost and quick effect, and has a promotion value.
- the medicine for treating a cold or the like is made of the following formula, and other formulas mentioned below refer to a formula of Fuyulinge tablets; a formula of strong Yinqiao tablets may also be used.
- the experience of the party is good, the effect is good, and the invention can also be used for treating atypical pneumonia.
- Treatment of lung diseases can be treated in the form of a mask or a gas mask. Direct attack on the lesion, just place the appropriate medication on the mask.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne différentes formulations pharmaceutiques, y compris des formulations destinées au traitement de la rugosité cutanée, avec un œstrogène en tant que composant principal; une formulation modifiée d'un comprimé de Huanglian Shangging pour le traitement de cancers, de l'hémiplégie due à une hémorragie cérébrale, de la psychose et des hémorroïdes; une formulation pharmaceutique destinée au traitement de l'avitaminose B1, avec de la vitamine C en tant que composant principal et avec une base pharmaceutiquement acceptable en tant qu'adjuvant pour préparer une formulation de poudre ou une formulation aqueuse; une formulation pharmaceutique destinée au traitement du rhume de cerveau, un médicament anti-rhume étant mélangé avec une base pharmaceutiquement acceptable, de la vitamine C pour accroître l'efficacité contre le rhume de cerveau, et d'autres plantes médicinales chinoises traditionnelles pour préparer une formulation en poudre ou une formulation de comprimés.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110086621.2 | 2011-03-28 | ||
CN2011100866212A CN102697975A (zh) | 2011-03-28 | 2011-03-28 | 治疗几种疾病的黄连上清片改进制剂 |
CN201110085976.X | 2011-03-30 | ||
CN201110085976XA CN102727625A (zh) | 2011-03-30 | 2011-03-30 | 一种治疗感冒的复方感冒灵片改进制剂 |
CN201110090748.1 | 2011-04-02 | ||
CN2011100907481A CN102727401A (zh) | 2011-04-02 | 2011-04-02 | 一种化妆品 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012129957A1 true WO2012129957A1 (fr) | 2012-10-04 |
Family
ID=46929398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2012/000061 WO2012129957A1 (fr) | 2011-03-28 | 2012-01-13 | Différentes formulations pharmaceutiques |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012129957A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105353063A (zh) * | 2015-12-07 | 2016-02-24 | 华润三九(郴州)制药有限公司 | 复方感冒灵流膏化学成分标准指纹图谱及构建方法、应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1213979A (zh) * | 1995-04-12 | 1999-04-14 | 安田三郎 | 治疗感冒用口罩 |
CN1045384C (zh) * | 1989-05-05 | 1999-10-06 | 程立志 | 治疗脚气药物的制备方法 |
CN1291474A (zh) * | 2000-10-19 | 2001-04-18 | 南京振中生物工程有限公司 | 紫杉醇脂质组合物及其制备方法 |
CN1086951C (zh) * | 1998-10-27 | 2002-07-03 | 曹生沅 | 一种治疗感冒的冲剂 |
CN1460465A (zh) * | 2003-06-13 | 2003-12-10 | 张炯怡 | 加有大豆异黄酮的化妆品 |
-
2012
- 2012-01-13 WO PCT/CN2012/000061 patent/WO2012129957A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1045384C (zh) * | 1989-05-05 | 1999-10-06 | 程立志 | 治疗脚气药物的制备方法 |
CN1213979A (zh) * | 1995-04-12 | 1999-04-14 | 安田三郎 | 治疗感冒用口罩 |
CN1086951C (zh) * | 1998-10-27 | 2002-07-03 | 曹生沅 | 一种治疗感冒的冲剂 |
CN1291474A (zh) * | 2000-10-19 | 2001-04-18 | 南京振中生物工程有限公司 | 紫杉醇脂质组合物及其制备方法 |
CN1460465A (zh) * | 2003-06-13 | 2003-12-10 | 张炯怡 | 加有大豆异黄酮的化妆品 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105353063A (zh) * | 2015-12-07 | 2016-02-24 | 华润三九(郴州)制药有限公司 | 复方感冒灵流膏化学成分标准指纹图谱及构建方法、应用 |
CN105353063B (zh) * | 2015-12-07 | 2018-04-24 | 华润三九(郴州)制药有限公司 | 复方感冒灵流膏化学成分标准指纹图谱及构建方法、应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104352587B (zh) | 一种治疗鼻炎的软膏 | |
CN103099948A (zh) | 一种治疗咽炎的药物组合物和制备方法 | |
CN106309577A (zh) | 一种用于治疗鼻炎的抑菌膏及其制备方法 | |
CN104840734B (zh) | 清咽保健中药组合物及其制备方法和应用 | |
CN110652552A (zh) | 一种伤口愈合配方及制备方法 | |
CN104257795A (zh) | 一种治疗感冒的药物 | |
CN108096344A (zh) | 一种治疗鼻炎的中药组合物 | |
WO2012129957A1 (fr) | Différentes formulations pharmaceutiques | |
CN103405602A (zh) | 一种治疗哮喘的药物 | |
CN107496558B (zh) | 一种治疗咳嗽的组合物及其应用 | |
CN104474405A (zh) | 一种治疗黄褐斑的中药组合物 | |
CN110237201A (zh) | 一种治疗慢性肺曲霉病的药品 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
CN103463236B (zh) | 一种药物组合物及其制备方法 | |
CN114949147B (zh) | 一种治疗慢性咽炎的中药组合物,其制备方法和应用 | |
CN111358927B (zh) | 蒲姜药物组合物及其应用 | |
CN104958653A (zh) | 一种治疗结核病的中药组合物 | |
CN104887808A (zh) | 一种治疗牙周炎的中药制剂 | |
CN106540051B (zh) | 治疗鼻炎的中药组合物、粉剂和膏剂及其制备方法 | |
CN105456708A (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
CN106361999A (zh) | 一种治疗口腔癌喷雾及其制备方法 | |
CN104435232B (zh) | 一种用于治疗牙痛的中药组合物 | |
WO2022126255A1 (fr) | Complément alimentaire antioxydant soutenant le système immunitaire | |
CN104189083A (zh) | 治疗急性上颌窦炎的中药制剂 | |
CN110721241A (zh) | 一种用于治疗慢性咽炎的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12763962 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12763962 Country of ref document: EP Kind code of ref document: A1 |